Results 131 to 140 of about 19,548 (244)

Opsoclonus‐Myoclonus‐Ataxia Syndrome Associated with Coexisting Anti‐N‐Methyl‐D‐Aspartate Receptor and Glial Fibrillary Acidic Protein Antibodies

Movement Disorders Clinical Practice, Volume 13, Issue 5, Page 1313-1317, May 2026.
Eriko Igami, Yutaka Oji, Akihiro Yamaguchi, Shin‐ichi Ueno, Yuji Tomizawa, Taiji Tsunemi, Taku Hatano, Nobutaka Hattori   +7 more
wiley   +1 more source

Profile of Xeomin® (incobotulinumtoxinA) for the treatment of blepharospasm

Clinical Ophthalmology, 2011
Juwan Park1, Michael S Lee2, Andrew R Harrison31Department of Ophthalmology, The Catholic University of Korea, Seoul, Korea; 2Department of Ophthalmology, Neurology and Neurosurgery, 3Department of Ophthalmology and Otolaryngology, University of ...
Park J, Lee MS, Harrison AR
doaj  

FTH1‐Related Neuroferritinopathy: A Rare Form of Neurodegeneration with Brain Iron Accumulation Mimicking Pontocerebellar Hypoplasia

Movement Disorders Clinical Practice, Volume 13, Issue 5, Page 1333-1335, May 2026.
Sayoni Roy Chowdhury, Sangeetha Yoganathan, Vivek Pai, Andrea LeBlanc‐Millar, Vann Chau, Roberto Mendoza‐Londono, Lucie Dupuis, Carolina Gorodetsky   +7 more
wiley   +1 more source

Botulinum toxin therapy: functional silencing of salivary disorders. [PDF]

, 2017
Botulinum toxin (BTX) is a neurotoxic protein produced by Clostridium botulinum, an anaerobic bacterium. BTX therapy is a safe and effective treatment when used for functional silencing of the salivary glands in disorders such as sialoceles and salivary ...
Lovato, A, Marchese Ragona, R., Marioni, Gino, Ottaviano, Giancarlo, Restivo, Da   +4 more
core  

The Potential Therapeutic Effects of Botulinum Neurotoxins on Neoplastic Cells: A Comprehensive Review of In Vitro and In Vivo Studies

Toxins
A systematic review of the literature found fifteen articles on the effect of a botulinum toxin on neoplastic cell lines and eight articles on in vivo neoplasms.
Delaram Safarpour, Fattaneh A. Tavassoli, Bahman Jabbari   +2 more
doaj   +1 more source

Clostridium botulinum neurotoxin [PDF]

Microbiological Reviews, 1980
openaire   +2 more sources

Intramuscular Botulinum Neurotoxin Serotypes E and A Elicit Distinct Effects on SNAP25 Protein Fragments, Muscular Histology, Spread and Neuronal Transport: An Integrated Histology-Based Study in the Rat

Toxins
Botulinum neurotoxins E (BoNT/E) and A (BoNT/A) act by cleaving Synaptosome-Associated Protein 25 (SNAP25) at two different C-terminal sites, but they display very distinct durations of action, BoNT/E being short acting and BoNT/A long acting.
Vincent Martin, Denis Carre, Heloise Bilbault, Sebastien Oster, Lorenzo Limana, Florian Sebal, Christine Favre-Guilmard, Mikhail Kalinichev, Christian Leveque, Virginie Boulifard, Catherine George, Stephane Lezmi   +11 more
doaj   +1 more source

Patient considerations in the treatment of cervical dystonia: focus on botulinum toxin type A

Patient Preference and Adherence, 2015
Reversa R Mills, Fernando L Pagan Department of Neurology, Movement Disorders and Neurorestoration Division, Georgetown University Hospital, Washington, DC, USA Abstract: Cervical dystonia is the most common form of focal dystonia characterized by
Mills RR, Pagan FL
doaj  

Botulinum Neurotoxins [PDF]

, 2012
Robert P., Virginia I., Leonard A.
openaire   +1 more source

From Gut to Systemic Circulation: Molecular Strategies of Botulinum Neurotoxin Complexes. [PDF]

Toxins (Basel)
Mondy J, Lemichez E.
europepmc   +1 more source